Menu
Search
|

Menu

Close
X

Clearside Biomedical Inc CLSD.OQ (NASDAQ Stock Exchange Global Market)

10.37 USD
-- (--)
As of 1:30 AM IST
chart
Previous Close 10.37
Open --
Volume --
3m Avg Volume 159,169
Today’s High --
Today’s Low --
52 Week High 15.27
52 Week Low 5.32
Shares Outstanding (mil) 25.34
Market Capitalization (mil) 211.56
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.62 Mean rating from 8 analysts

KEY STATS

Revenue (mm, USD)
FY18
0
FY17
0
FY16
1
FY15
0
EPS (USD)
FY18
-0.619
FY17
-2.329
FY16
-1.046
FY15
-4.128
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.76
Price to Sales (TTM)
vs sector
1,459.03
5.73
Price to Book (MRQ)
vs sector
3.89
5.47
Price to Cash Flow (TTM)
vs sector
--
23.29
Total Debt to Equity (MRQ)
vs sector
14.35
16.84
LT Debt to Equity (MRQ)
vs sector
11.41
12.51
Return on Investment (TTM)
vs sector
-71.32
14.61
Return on Equity (TTM)
vs sector
-78.78
16.34

EXECUTIVE LEADERSHIP

Christy Shaffer
Chairman of the Board, Since 2012
Salary: --
Bonus: --
Daniel White
President, Chief Executive Officer, Director, Since 2011
Salary: $334,750.00
Bonus: $50,000.00
Charles Deignan
Chief Financial Officer, Since 2012
Salary: $257,500.00
Bonus: $30,000.00
Glenn Noronha
Chief Scientific Officer, Since 2016
Salary: $286,365.00
Bonus: $30,000.00
Rafael Andino
Vice President - Engineering & Manufacturing, Since
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

900 N Point Pkwy Ste 200
ALPHARETTA   GA   30005-8995

Phone: +1678.2703631

Clearside Biomedical, Inc. is a clinical biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye. The Company's product candidates focus on diseases affecting the retina, which is the tissue that lines the inside of the eye and is primarily responsible for vision, and the choroid, which is the layer adjacent to the retina that supplies the retina with blood, oxygen and nourishment. With its microinjector, drugs are injected into and spread within and through the suprachoroidal space, (SCS), which is the space located between the choroid and the outer protective layer of the eye known as the sclera. With the suprachoroidal injection, its product candidates are more directly administered to the retina and choroid as compared to other ocular drug administration techniques, such as injections of drug into the vitreous, a jelly-like substance that occupies the central portion of the eye.

SPONSORED STORIES